Opinion: America’s disease surveillance system is going dark. Here’s what we can build to replace it
Stat News • 2/13/2026
Summary
America’s disease surveillance system is broken. There are proposals on how to replace it.
Advertisement
Lindy Score Breakdown (V4.2)
50d
Age
1
Sources
from cluster
1201
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1201/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1201/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 50 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 2 days ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • 1 day ago
Opinion: My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine
Stat News • 1 day ago
Opinion: STAT+: Cardiology’s finally prioritizing prevention — but what will it look like?
Stat News • 2 days ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more
Stat News • 2 days ago
STAT+: Insilico Medicine CEO on how best to use AI in drug development
Stat News • 2 days ago
STAT+: Novo’s subscription model raises questions about pharma-telehealth tie-ups
Stat News • 2 days ago
STAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interest
Stat News • 2 days ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • Today
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago